AVENUE THERAPEUTICS INC (ATXI:OTCMKTS)
$0.52 -0.05505 (-9.5731%)
Analysed AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) News Sources
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
23-02-2026
yahoo.com
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
06-11-2025
yahoo.com
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
06-11-2025
yahoo.com
Delisting of Securities from The Nasdaq Stock Market
11-07-2025
yahoo.com
What is the current price of AVENUE THERAPEUTICS INC (ATXI:OTCMKTS)?
The current price of AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) is $0.52.
AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) since the previous trading day is $-0.05505.
AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) since the previous trading day is -9.5731%.
What is the most recent average sentiment score for AVENUE THERAPEUTICS INC (ATXI:OTCMKTS)?
The most recent average sentiment score for AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for AVENUE THERAPEUTICS INC (ATXI:OTCMKTS)?
The most recent sentiment for AVENUE THERAPEUTICS INC (ATXI:OTCMKTS) is .
SEC-8K** Filing Available For AVENUE THERAPEUTICS INC (ATXI:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.